Evidence map›Paper›PMID 30356352›Full record

Trial reportBioMed research international2018

Awareness and Vaccine Coverage of Hepatitis B among Cameroonian Medical Students.

Desmond Aroke, Benjamin Momo Kadia, Ephesians Nkwetta Anutebeh, Cluade Asaba Belanquale, Glory Masango Misori, Alfred Awa, Clarence M Mbanga, Larry Tangie Ngek

Open access · hybridAbstract readClinical Trial
In one paragraph

Trial report in BioMed research international, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Desmond ArokeFontem District Hospital, Fontem, Cameroon.ORCID 0000-0001-7557-7777
Benjamin Momo KadiaGrace Community Health and Development Association (GRACHADA), Kumba, Cameroon.ORCID 0000-0002-8566-7132
Ephesians Nkwetta AnutebehFaculty of Health Sciences, University of Buea, Buea, Cameroon.
Cluade Asaba BelanqualeFaculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon.
Glory Masango MisoriHealth and Human Development (2HD) Research Network, Douala, Cameroon.
Alfred AwaNdop District Hospital, Ndop, Cameroon.
Clarence M MbangaMankon Sub-Divisional Hospital, Bamenda, Cameroon.
Larry Tangie NgekFaculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon.
Université de Yaoundé I · CMUniversity of Buea · CMHealth and Human Development (2HD) Research Network · CMLondon School of Hygiene & Tropical Medicine · GBUniversity of Bamenda · CM

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe endemic nature of the hepatitis B virus (HBV) in Sub-Saharan Africa is a significant public health problem that places health care providers (medical students inclusive) at increased risk of occupational exposure. However vaccination against HBV is not systematic among medical students in Cameroon. Thus, we sought to evaluate awareness and HBV vaccine coverage among medical students in Cameroon.

methodsUsing semistructured questionnaire and a cross-sectional approach, medical students from 3 State Universities in Cameroon were evaluated for their knowledge, attitudes, and vaccination status against the HBV. Data were collected over a 3-month period. HBV vaccine status was defined as complete (3 doses), partial (1 and 2 doses), and unvaccinated. Data were entered and analyzed using Epi-info 7.

resultsThere were 714 respondents among whom 186 (26.05%) had been vaccinated at least once against HBV. Sixty-six (9.24%) were partially vaccinated and 120 (16.81%) completely vaccinated. No student had done postvaccination serologic testing to confirm full immunisation. Eighty-three percent (83.00%) of respondents had adequate knowledge on HBV infection and vaccine, while 90.00% had adequate knowledge on HBV transmission. Most medical students had a positive attitude towards the HBV vaccine. The most common negative attitudes were worries about the side effects and fears of being infected by the vaccine.

conclusionDespite adequate knowledge on HBV infection and vaccination only about 1 in 6 medical students had completed the HBV vaccination series. This highlights the need for better health policies aimed at increasing access and coverage of the HBV in at-risk populations like medical students.

Indexed as

Schools, MedicalStudent Health ServicesSurveys and QuestionnairesVaccinationAdultCameroonCross-Sectional StudiesFemaleHepatitis BHepatitis B VaccinesHumansMaleHepatitis B Vaccines

Identifiers

PMID30356352
PMCPMC6176293
OpenAlexW2893340301

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.